Kalaris Therapeutics, Inc. (KLRS)
NASDAQ: KLRS · Real-Time Price · USD
2.620
+0.060 (2.34%)
At close: Jun 27, 2025, 4:00 PM
2.520
-0.100 (-3.82%)
After-hours: Jun 27, 2025, 7:01 PM EDT

Kalaris Therapeutics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024 FY 2023 FY 2022
Period Ending
Jun '25 Dec '24 Dec '23 Dec '22
Debt / Equity Ratio
--0.39--0.61
Quick Ratio
14.140.070.800.54
Current Ratio
14.310.110.850.69
Return on Assets (ROA)
--681.04%-232.72%-
Buyback Yield / Dilution
-64.52%-9.18%-36.56%-
Updated Mar 18, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.